JITC Publishes OncoHost Study Identifying Predictive Proteomic Signature to Analyze Treatment Resistance in NSCLC Patients

/PRNewswire/ -- OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, today announced a peer-reviewed...

Related Keywords

Alona ,H Efa ,Israel ,Binyamina ,Israeli ,Ofer Sharon ,Yuval Shaked ,Kellie Hanson ,Michal Harel ,Adam Dicker ,David Carbone ,Institute Of Oncology At Sheba Medical Center ,Linkedin ,Twitter ,James Thoracic Center ,Facebook ,Israel Institute Of Technology ,Thomas Jefferson University ,Peer Reviewed Paper Reveals Potential Biomarkers ,Patient Blood Plasma ,Assess Patient Resistance ,Chief Scientific Advisor ,Chief Medical Officer ,Jair Bar ,Deputy Director ,Sheba Medical Center ,Alona Zer ,Medical Oncology ,Rambam Health Care ,Oncohost ,Biotechnology ,Pharmaceuticals ,Medical Pharmaceuticals ,Health Care Amp Hospitals ,Surveys ,Olls And Research ,